Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors
2016
Background Benefits and risks of
angiotensin converting enzymeinhibitors (ACE-I) in advanced chronic
kidney disease(CKD) are controversial. We tested the role of ACE-I in slowing the progression of renal damage in a real-world elderly population with CKD stage 5.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
34
References
2
Citations
NaN
KQI